Results 281 to 290 of about 207,949 (383)

Patients with Benzodiazepine Intoxication Require Neurological and Psychiatric Examination in Order to Guide and Monitor Withdrawal. [PDF]

Indian J Crit Care Med
Zarrouk S, Finsterer J.
europepmc   +1 more source

Recent Advances in the Synthesis of Annelated 1,4-Benzodiazepines

, 1986
Chengalva Venkata Ratnam, Ghulam Mohiuddin, P. S. N. REDDY, Ahmed Khalil   +3 more
openalex   +1 more source

The association of prescriber prominence in a shared-patient physician network with their patients receipt of and transitions between risky drug combinations. [PDF]

Appl Netw Sci
O'Malley AJ, Meara E, Morden NE, Moen EL, Ran X.   +4 more
europepmc   +1 more source

ABUSE OF BENZODIAZEPINES

British Journal of Anaesthesia, 1983
openaire   +3 more sources

Benzodiazepines: a summary of pharmacokinetic properties.

, 1981
D J Greenblatt, Richard I. Shader, Marcia Divoll, JS Harmatz   +3 more
openalex   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research

Addiction, EarlyView.
James S. H. Wong, Anthony Lau, Pouya Azar   +2 more
wiley   +1 more source

Evidence that 5‐HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs

British Journal of Pharmacology, EarlyView.
Background and Purpose Serotonergic psychedelic drugs are under investigation as therapies for various psychiatric disorders, including major depression. Although serotonergic psychedelic drugs are 5‐HT2A receptor agonists, some such agonists are not psychedelic, potentially due to differences in 5‐HT2A receptor ligand bias or signalling efficacy. Here,
Aurelija Ippolito, Sridhar Vasudevan, Shaun Hurley, Gary Gilmour, Frederick Westhorpe, Grant Churchill, Trevor Sharp   +6 more
wiley   +1 more source

Changes over time in novel benzodiazepines contributing to fatal overdoses in Victoria, Australia. [PDF]

Drug Alcohol Rev
Schumann JL, Syrjanen R, Dwyer JA.
europepmc   +1 more source

Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABAA receptors

British Journal of Pharmacology, EarlyView.
Abstract Background and purpose Positive allosteric modulation of the P2X4 receptor is a potential route to providing cardiovascular benefit through enhancing flow‐dependent arterial vasodilation and providing cardioprotection. However, ligands that selectively enhance P2X4 activity are absent.
Jessica L. Meades, Marcella Bassetto, Marius C. Staiculescu, Gayathri Swaminath, Samuel J. Fountain   +4 more
wiley   +1 more source